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Bactéries Pathogènes Entériques, Centre National de Référence des Escherichia coli, Shigella et Salmonella, Paris, FranceAbstractShiga toxins (Stxs) are potent cytotoxins that inhibit host cell protein synthesis, leading to cell death. Classically, these toxins are associated
with intestinal infections due to Stx-producing Escherichia coli or Shigella dysenteriae serotype 1, and infections with these strains can lead to
haemolytic–uraemic syndrome. Over the past decade, there has been increasing recognition that Stx is produced by additional Shigella
species. We recently reported the presence and expression of stx genes in Shigella ﬂexneri 2a clinical isolates. The toxin genes were
carried by a new stx-encoding bacteriophage, and infection with these strains correlated with recent travel to Haiti or the Dominican
Republic. In this study, we further explored the epidemiological link to this region by utilizing the French National Reference Centre for
Escherichia coli, Shigella and Salmonella collection to survey the frequency of Stx-producing Shigella species isolated from French travellers
returning from the Caribbean. Approximately 21% of the isolates tested were found to encode and produce Stx. These isolates included
strains of S. ﬂexneri 2a, S. ﬂexneri Y, and S. dysenteriae 4. All of the travellers who were infected with Stx-producing Shigella had recently
travelled to Haiti, the Dominican Republic, or French Guiana. Furthermore, whole genome sequencing showed that the toxin genes were
encoded by a prophage that was highly identical to the phage that we identiﬁed in our previous study. These ﬁndings demonstrate that
this new stx-encoding prophage is circulating within that geographical area, has spread to other continents, and is capable of spreading to
multiple Shigella serogroups.
Clinical Microbiology and Infection published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.
Keywords: Dominican Republic, Haiti, Shiga toxin, Shigella
Original Submission: 3 February 2015; Revised Submission: 1 May 2015; Accepted: 2 May 2015
Editor: F. Allerberger
Available online 14 May 2015Corresponding author: A.T. Maurelli, Department of Microbiology
and Immunology, F. Edward Hébert School of Medicine, Uniformed
Services University of the Health Sciences, Bethesda, MD, USA
E-mail: anthony.maurelli@usuhs.eduIntroductionShiga toxins (Stxs) are cytotoxins that act by inhibiting
eukaryotic protein synthesis, eventually leading to host cell
death [1]. Stxs are classiﬁed as AB5 toxins on the basis of their
structure [2]. They consist of an enzymatically active A subunit,Clinical Microbiology and Infection published by Elwhich shows RNA N-glycosidase activity, and a B pentamer,
which is responsible for binding of the toxin to glycolipid re-
ceptors on the target cell surface. After binding, Stx enters a
mammalian cell by endocytosis, and eventually trafﬁcs to the
endoplasmic reticulum, where the A subunit is proteolytically
cleaved to an inactive, A2 subunit and an active A1 subunit,
which binds to and inactivates the host cell ribosome [3]. In-
fections with bacteria that produce Stx can cause haemorrhagic
colitis and lead to more serious complications such as hae-
molytic–uraemic syndrome, a potentially deadly condition [4].
Although Stxs are commonly made by Shigella dysenteriae
serotype 1 and Stx-producing Escherichia coli (STEC), stx genes
have recently been found in other Shigella species [5–7].Clin Microbiol Infect 2015; 21: 765.e9–765.e14
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765.e10 Clinical Microbiology and Infection, Volume 21 Number 8, August 2015 CMIS. dysenteriae 1 produces the prototypical Stx, which is encoded
on the chromosome within a defective bacteriophage [8]. Stx is
secreted by S. dysenteriae 1 via an unknown mechanism. In
STEC, the Stx family is composed of two different branches,
Stx1 and Stx2, which contain many subtypes and variants that
are antigenically related [9]. Stxs in the Stx1 family are nearly
identical to S. dysenteriae 1 toxin, whereas subtypes from the
Stx2 family share approximately 50% homology with Stx
[10,11]. In contrast to S. dysenteriae 1, the toxin genes in STEC
are encoded by lambdoid prophages, and toxin release occurs
through lytic induction of the prophage [12–14].
In a previous study, we analysed 26 clinical isolates from US
public health department laboratories of Shigella ﬂexneri 2a that
produce and release Stx [6]. The toxin genes in these isolates
are carried by a new stx-converting phage, ΦPOC-J13. These
S. ﬂexneri isolates were identiﬁed on the basis of their shared
pulsed-ﬁeld gel electrophoresis (PFGE) pattern in the CDC
PulseNet database. Additionally, of the patients who reported
foreign travel, ~60% had recently visited the island of Hispaniola
(Haiti and the Dominican Republic), suggesting that the emer-
gence of these strains is associated with that region.
Here, we further investigated this link between infection
with Stx-producing Shigella and travel to Hispaniola by
surveying the occurrence of stx-encoding Shigella species in
French travellers returning from the Caribbean. Approximately
50–60% of all Shigella isolates from France and its overseas
‘départements’ (administrative subdivisions) are reported to
the French National Reference Centre for Escherichia coli,
Shigella and Salmonella (FNRC-ESS), located at the Institut
Pasteur, Paris, France. The collection includes all serogroups of
Shigella, and epidemiological data (date and site of isolation,
gender, age, and international travel history) are recorded for
each case. We utilized the FNRC-ESS collection of Shigella
species from French travellers who had reported recent travel
to the Caribbean to screen for stx. The ﬁndings reported here
support our hypothesis that emergence of Stx-producing
Shigella is occurring within Hispaniola, show that the stx-con-
verting phage responsible has spread to other Shigella species,
and demonstrate that Stx-producing Shigella has spread globally.Materials and methodsBacterial strains and growth conditions
Shigella strains were grown in Tryptic Soy Broth (BD Difco,
Franklin Lakes, NJ, USA) at 37°C with aeration, or on Tryptic
Soy Broth plates containing 1.5% agar and 0.025% Congo red
(Sigma-Aldrich, St Louis, MO, USA). E. coli K-12 strain MG1655
was grown in Luria–Bertani broth and on Luria–Bertani agar
plates.Clinical Microbiology and Infection published by Elsevier Ltd on behalf of European Society of CTaxonomic identiﬁcation of isolates
Shigella ‘species’ identiﬁcation was conﬁrmed with conventional
methods, and serotyping was performed by slide agglutination
assays with a complete set of antisera allowing recognition of all
described Shigella serotypes [15]. The results of whole genome
sequencing conﬁrmed identiﬁcation of the isolates.
PCR analysis of Shigella clinical isolates
DNA was extracted from the Shigella clinical isolates with the
InstaGene matrix kit (Bio-Rad, Hercules, CA, USA), and
screened by PCR for stx with the previously described primers
Lin 50 and Lin 30, which detect stx and its variants [16,17].
Subsequent PCR with primers Lin 50 and VT1b allowed
detection of most variants of stx1, and a PCR with primers Lin 50
and stx2-R allowed detection of most variants of stx2. Similarly,
DNA extracts were screened for stx2 with primers Lin 50 and
stx2-R [16,18]. Strains that were positive for stx by PCR were
further subtyped according to the consensus international
methods described in Scheutz et al. [9]. The PCRs were carried
out with a PCR Taq DNA polymerase kit (Applied Biosystems/
Roche, Foster City, CA, USA).
Cell lysates from the stx-encoding isolates were analysed by
PCR with primer pairs Stx1R2/Phage_stxR2 and Phage_stx1F2/
Stx1F2 to show that stx was phage encoded [6]. The insertion
site of the phage into locus S1742 or a homologous gene was
determined by PCR with primers for the upstream region of
S1742 and an early phage gene (primers S1742_up and
Stx_phage_up), and by amplifying a late phage gene and the
downstream region of S1742 with primers Stx_phage_dn and
S1742_dn [6]. These PCRs were carried out with PCR Master
Mix 2X according to the manufacturer’s speciﬁcation (Fer-
mentas, Pittsburgh, PA, USA).
Cytotoxicity assay
Whole cell lysates and supernatants from the stx-encoding
isolates were tested in a Vero cell cytotoxicity assay as previ-
ously described [6].
Determination of plaque-forming units
Phage particles were isolated from overnight supernatants and
absorbed onto E. coli MG1655 as previously described [6].
Plaque plates were incubated overnight at 37°C before plaque-
forming units were enumerated. The plaques observed were
veriﬁed to be due to an stx-encoding phage by spotting 50 μL of
phage prepared from overnight supernatants onto a soft agar
overlay of MG1655. After overnight incubation at 37°C, the
zone of clearing from where the phage preparation was spotted
was removed and analysed by PCR with primers stx1-det-F1
and stx1-seq-R1 to detect stx [9]. To conﬁrm that the PCR
product from the overlay was not due to bacteriallinical Microbiology and Infectious Diseases, CMI, 21, 765.e9–765.e14
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producing strain was spotted, and was shown to be stx-negative.
Whole genome sequencing and analysis
Genomic DNA was extracted from overnight cultures with the
DNeasy Blood and Tissue Kit (Qiagen, Valencia, CA, USA).
Sequencing libraries were prepared with either the TruSeq
DNA Sample Prep Kit (Illumina, San Diego, CA, USA) or the
Nextera DNA Sample Prep Kit (Illumina). DNAs were
sequenced on the Illumina MiSeq Platform, generating paired-
end 250-bp reads in sufﬁcient quantity to provide over ×35
coverage for each genome. Raw reads were trimmed and draft
genome sequences were assembled de novo with CLC Geno-
mics Workbench v6.5.1 or v7.0.4 (CLC bio, Boston, MA, USA).
In most cases, the entire phage harbouring stx was contained on
one contig; otherwise, two contigs were bioinformatically
joined to obtain the entire phage sequence, and this was then
veriﬁed by mapping the reads onto the phage sequence.
The stx-encoding prophage sequences were extracted from
the genomic assemblies of the isolates investigated and aligned
to the ΦPOC-J13 phage reference sequence (GenBank acces-
sion KJ603229) with the Mauve algorithm within the MegAlign
Pro module of the Lasergene software package (DNASTAR,
Madison, WI, USA). Phylogenetic analysis of identiﬁed single-
nucleotide polymorphisms (SNPs) was conducted with Split-
sTree 4 [19], by use of the neighbour-net algorithm and un-
transformed p distances.
PFGE
PFGE was performed according to the protocol developed by
the CDC (http://www.cdc.gov/pulsenet/pathogens/index.html),
with Salmonella enterica serotype Braenderup H9812 as the
control strain. Agarose-embedded DNA was digested with
50 U of XbaI (Roche Diagnostics, Indianapolis, IN, USA) for at
least 2 h in a water bath at 37°C. The restriction fragments
were separated by electrophoresis in 0.5X TBE bufferTABLE 1. stx-positive Shigella isolates from French travellers
Isolate Species Year of isolation Reported trave
BS1021 S. ﬂexneri 2a 2003 Haiti
BS1022 S. ﬂexneri 2a 2004 Dominican Repub
BS1023 S. ﬂexneri 2a 2005 Dominican Repub
BS1024 S. ﬂexneri 2a 2005 French Guiana
BS1025 S. ﬂexneri 2a 2008 Haiti
BS1041 S. ﬂexneri 2a 1999 Dominican Repub
BS1042 S. ﬂexneri 2a 2005 Dominican Repub
BS1043 S. ﬂexneri Y 2005 Haiti
BS1044 S. ﬂexneri 2a 2005 Dominican Repub
BS1045 S. ﬂexneri 2a 2007 Dominican Repub
BS1046 S. ﬂexneri 2a 2008 Dominican Repub
BS1047 S. dysenteriae 4 2008 Haiti
aFor some patients, the exact age was not recorded, but was rather described as a range.
Clinical Microbiology and Infection published by Elsevier Ltd on behalf of Eur(Invitrogen, Carlsbad, CA, USA) at 14°C for 18 h with a Chef
Mapper electrophoresis system (Bio-Rad) and pulse times of
2.16–54.17 s. The gels were stained with GelRed Nucleic Acid
Stain (Phenix Research, Candler, NC, USA), and DNA bands
were visualized with UV transillumination (Bio-Rad). PFGE re-
sults were analysed with BioNumerics Software v6.6 (Applied-
Maths, Kortrijk, Belgium), and banding pattern similarity was
compared by use of a 1.5% band position tolerance.
Nucleotide sequence accession numbers
The Whole Draft Genome sequences have been deposited at
DDBJ/EMBL/GenBank under the accession numbers listed in
Table 1.ResultsA review of records between 1994 and 2008 revealed 67
Shigella isolates submitted to the FNRC-ESS that had been
obtained from patients who had reported recent travel to Haiti
or the Dominican Republic. Of the 67 isolates, 51 were tested
for stx by PCR. The remaining 16 isolates were either not
found in the collection or were not viable. Four randomly
selected Shigella isolates from French Guiana, a French over-
seas ‘département’ in South America, plus one isolate from a
traveller returning from French Guiana were also included in
the analysis. The isolates included all serogroups of Shigella
(Shigella boydii, S. dysenteriae, S. ﬂexneri, and Shigella sonnei). Of
the 51 isolates from patients for whom travel to either Haiti or
the Dominican Republic had been reported, 11 were found to
be stx-positive. This included nine S. ﬂexneri 2a isolates, one
S. dysenteriae 4 isolate, and one S. ﬂexneri Y isolate. An
S. ﬂexneri 2a isolate from a traveller returning from French
Guiana was also stx-positive; however, the four randomly
selected French Guiana isolates were negative for stx by PCR.
Additionally, all of the isolates analysed were found to be stx2-l Age (years)a Gender GenBank accession no.
1–5 Female LAHV01000000
lic 15–64 Male LAHW01000000
lic 8 Male LAHX01000000
15–64 Male LAHY01000000
13 Male LAHZ01000000
lic 4 Female LAIA01000000
lic 4 Female LAIB01000000
39 Male LAIC01000000
lic 1–5 Female LAID01000000
lic 31 Male LAIE01000000
lic 4 Female LAIF01000000
50 Male LAIG01000000
opean Society of Clinical Microbiology and Infectious Diseases, CMI, 21, 765.e9–765.e14
FIG. 1. stx-encoding Shigella species from French travellers release a
functional toxin. Overnight supernatants were serially diluted ten-fold
in medium, and applied to Vero cells to test for toxicity. Stx from
Shigella dysenteriae 1 was included as a positive control. CD50/mL is
deﬁned as the reciprocal of the dilution of Stx that kills 50% of Vero
cells. Data represent an average of three independent experiments.
765.e12 Clinical Microbiology and Infection, Volume 21 Number 8, August 2015 CMInegative. Limited clinical data were available; however, the
patients presented with symptoms of an intestinal infection
characteristic of shigellosis. Travel, isolation date and patient
information for the 12 stx-positive isolates are shown in
Table 1.
The 12 stx-positive isolates were further characterized by
determining whether they produced a functional toxin. Su-
pernatants from overnight cultures of the stx-encoding Shigella
isolates were cytotoxic to Vero cells as compared with an stx-
negative laboratory strain of S. ﬂexneri, 2457T (Fig. 1). The
CD50/mL values for the clinical isolates ranged between
~1.5 × 102 and ~5 × 105, demonstrating that all of the stx-
positive isolates produced and released toxin. As the toxin
genes are typically encoded by lambdoid prophages, we also
monitored for the presence of viable phage progeny in
overnight supernatants by performing a plaque assay with the
E. coli indicator strain MG1655. Eight of the isolates formed
plaques on MG1655. Viable phage progeny were not detected
from three S. ﬂexneri 2a isolates (BS1022, BS1045, and
BS1046) and the S. ﬂexneri Y isolate (BS1043). Failure of su-
pernatants from these four isolates to produce plaques on
MG1655 may be due to resistance of MG1655 to the phage
or to mutations resulting in a defective phage (see sequencing
analysis below).
Although the plaque assay demonstrated that the isolates
were making viable phage progeny, we wanted to conﬁrm that
the plaques observed were due to an stx-encoding phage. In
order to harvest enough DNA, we used a phage-spotting assay
on MG1655, and performed PCR analysis from the zone of
clearing. All of the isolates that formed plaques on MG1655
formed a zone of clearing and were stx positive, except forClinical Microbiology and Infection published by Elsevier Ltd on behalf of European Society of CBS1047 (data not shown). Although it is not completely clear
why BS1047 was capable of forming plaques when incubated
with MG1655 in liquid culture but did not produce a zone of
clearing in the spotting assay, differences between the two as-
says could probably explain this.
In our previous study, we designed primers based on the
ΦPOC-J13 sequence to show that the stx genes in all 26 of the
isolates analysed in that study were ﬂanked by phage sequence.
We utilized those primers to analyse the 12 stx-positive isolates
from the French travellers, and found that their stx locus was
also surrounded by a phage sequence similar to ΦPOC-J13
(data not shown). Additionally, our previous analysis showed
that ΦPOC-J13 is inserted in the S. ﬂexneri chromosome at
locus S1742, which encodes a putative oxidoreductase. On the
basis of our primer sequences designed from ΦPOC-J13, we
determined that the phage in each of the 12 stx-positive French
isolates had also inserted at locus S1742 or a homologous gene
(data not shown).
Our PCR analyses and the travel link to Hispaniola suggested
that the phage in the Shigella isolates from the French travellers
is also ΦPOC-J13. To investigate the similarity to ΦPOC-J13,
whole genome sequencing was performed on all 12 isolates.
The DNA sequences of the stx-encoding prophages from the 12
isolates were aligned and compared with ΦPOC-J13 (GenBank
accession KJ603229) (Fig. 2a). The set of 13 prophages were
nearly identical in sequence, with only 13 SNPs being identiﬁed
among them, mostly within hypothetical or putative protein-
encoding regions. Three insertion/deletion sites were
observed in isolates BS1024, BS1041, BS1045, and BS1046. In
addition to the 13 SNPs and three insertion/deletion sites, four
IS elements were observed among the isolates investigated
(Fig. 2a). Isolate BS1022 contained an IS1 element in an inter-
genic region and an IS2 element in a 2022-bp gene encoding a
tail ﬁbre protein. Isolate BS1046 also contained an IS2 element
inserted in a large, 8.4-kb hypothetical protein-encoding gene.
Finally, isolate BS1047 contained an IS2 element within a 546-bp
putative tail ﬁbre adhesin-encoding gene. It is uncertain what
affect these mutations may have on Stx production and the
production of infectious phage particles; however, it is possible
that they may account for the varying results that were
observed in our assays above.
The 13 SNPs identiﬁed were used to construct a phyloge-
netic tree of the relationships among the stx-encoding pro-
phages from the 12 isolates investigated and ΦPOC-J13
(Fig. 2b). The resulting unrooted phylogeny places the prophage
from isolate BS1022 (minus the two IS elements) as the po-
tential founder, with eight of the prophages being only one SNP
different from the BS1022 prophage sequence. The prophages
from isolates BS1047 and ΦPOC-J13 are the most divergent,
with three and four SNP differences from the BS1022linical Microbiology and Infectious Diseases, CMI, 21, 765.e9–765.e14
FIG. 2. stx-encoding prophage sequence similarity. (a) Single-nucleotide polymorphisms (SNPs), insertion/deletion (indel)sites and IS elements within the
prophage sequences of the isolates investigated. SNP locations are indicated by vertical black lines, and indel sites by blue lines. The locations and ori-
entations of the IS1 and IS2 elements are indicated by the green and red arrows, respectively. (b) SNP-based phylogenetic relationships of the prophages.
CMI Gray et al. Stx-producing Shigella from French travellers 765.e13prophage, respectively. These ﬁndings indicate that all of the
Stx-producing Shigella species isolated have acquired the same
phage.
The Stx-producing S. ﬂexneri 2a isolates from our previous
study were identiﬁed in PulseNet on the basis of their shared
PFGE pattern, JZXX01.0357. To determine whether these new
isolates shared the same signature pattern, PFGE was per-
formed on seven of the isolates from the French travellers.
None of the patterns matched JZXX01.0357 (BS937). More-
over, each of the seven PFGE patterns was different (Fig. 3).
Only one of the isolates (S. ﬂexneri 2a, BS1045) had a pattern
number already in the PulseNet Database, JZXX01.1361. We
used this pattern to search for matches, and found two isolates
that were 100% matched: one isolate from the Massachusetts
state laboratory, and one isolate from the Maryland state
laboratory.FIG. 3. Dendrogram of pulsed-ﬁeld gel
electrophoresis (PFGE) analysis (XbaI) of
Stx-producing Shigella. The PFGE pat-
terns from seven of the Stx-producing
Shigella isolates from French travellers
(BS1044, BS1046, BS1042, BS1043,
BS1045, BS1041, and BS1047) are
compared with that of BS937 (PulseNet
PFGE pattern JZXX01.0357).
Clinical Microbiology and Infection published by Elsevier Ltd on behalf of EurDiscussionOverall, 12 of 56 (~21%) Shigella isolates analysed from the
FNRC-ESS collection of French travellers returning from the
Caribbean were found to produce Stx. This ﬁnding reinforces
our hypothesis that the emergence of stx-encoding Shigella
species is originating from Haiti and the Dominican Republic.
Furthermore, the ﬁnding that the isolates from the French
travellers did not share the same PFGE pattern with each other,
or with the previously published Stx-producing S. ﬂexneri 2a
strains, highlights the importance of using multiple approaches
to identify these new strains of stx-encoding Shigella.
This is the ﬁrst report of this new stx-encoding phage har-
boured in different Shigella species and serotypes, indicating that
ΦPOC-J13 and homologous stx-encoding phages are capable of
spreading to multiple Shigella species. Because we have limitedopean Society of Clinical Microbiology and Infectious Diseases, CMI, 21, 765.e9–765.e14
765.e14 Clinical Microbiology and Infection, Volume 21 Number 8, August 2015 CMIclinical information on the isolates, the health consequences of
infection with Stx-producing Shigella remain unclear. However,
infections with S. dysenteriae 1 and STEC result in complications
of haemolytic–uraemic syndrome in ~10% of cases [20].
Therefore, these new Stx-producing Shigella isolates have the
potential to cause more severe disease than is typically asso-
ciated with non-S. dysenteriae type 1 infections.
Finally, we have now identiﬁed Stx-producing Shigella in both
French and US travellers who had recently visited the island of
Hispaniola. We have also isolated stx-positive Shigella from
Haitian children in Haiti (manuscript in preparation). It is still
uncertain what environmental factors have contributed to the
emergence of these species in that region. However, our
ﬁndings imply that travellers are capable of spreading these
Shigella strains globally. It is impossible to predict the extent of
international spread of Stx-producing Shigella. Nonetheless, one
could speculate that, as the strains spread, they may become
capable of persisting in the ecosystems of other regions, and
that the stx-encoding phage may spread to other Shigella species
in those regions. If either of those phenomena occurs, in-
fections with Stx-producing Shigella may become more preva-
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